San Rafael, California, February 20, 2018 – NewGen Surgical, maker of sustainably designed medical devices and surgical products, announced today the appointment of new board member David Kiger. Mr. Kiger, Bioclinica’s Chief Commercial Officer, will provide board leadership to go-to-market teams while accelerating the growth of NewGen Surgical’s business.
“As NewGen Surgical expands both in product offerings and into new markets, we are excited to welcome David Kiger to our board,” said Rob Chase, Founder and President of NewGen Surgical. “David’s expertise as a commercial strategist will help ensure NewGen Surgical’s integrated commercial success. His strong technical knowledge in healthcare along with his strong marketing and business development skills will be invaluable to our company as we achieve our long-term objectives.”
Mr. Kiger brings a wealth of experience as a senior commercial leader with deep pharmaceutical industry and domain knowledge of medical imaging and technology. Currently, Mr. Kiger provides leadership to Bioclinica’s alignment teams while strengthening their value propositions. Previously Mr. Kiger was Vice President, Product Strategy and Marketing Business Partner at PAREXEL where he defined go-to-market approaches and launches in the areas of patient, clinical, and regulatory technologies. Mr. Kiger brings a diversified career of 25 years of experience in business development, product and digital marketing, product management, alliances, and management consulting at companies such as Commerce One, Siebel Systems, and Accenture.
Mr. Kiger earned a bachelor’s degree in Business Administration, Computer Information Systems, and graduated Summa Cum Laude from the University of Wisconsin-Whitewater.